A new study reveals a simple and fast, label-free way to distinguish aggressive cancer cells by how they physically behave.

Cancer treatment is entering a new era, driven by advances in precision medicine, AI, and targeted therapies known as theranostics. In this episode of Today in Tech, Keith Shaw speaks with Douglas ...

The ability to identify patients at increased risk for hereditary cancer has never been more achievable, yet it’s still far from routine. National guidelines and accreditation programs call for ...

Researchers developed a liquid biopsy method that improved detection of live circulating tumor cells in triple negative ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

FLINT, MI - McLaren Flint has expanded its breast cancer screening and risk assessment capabilities by implementing Volpara Risk Pathways. The software is designed to streamline risk evaluation and ...

Cancer has a high death rate with delayed diagnosis of the disease being one of the main reasons for its fatality. Early diagnosis of cancer is vital to improving patient outcomes and in recent years, ...

Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated ...

Despite the development of numerous cancer treatment technologies, the common goal of current cancer therapies is to eliminate cancer cells. This approach, however, faces fundamental limitations, ...

Colorectal cancer is the second-leading cause of cancer related death in the U.S., with nearly 53,000 1 fatalities expected in 2025. While the burden of this disease is significant, advancements in ...